Mephedrone interactions with cocaine: Prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats

Behavioural Pharmacology

Volumn 24, Issue 8, 2013, Pages 684-688

  Gregg, Ryan A ^a   Tallarida, Christopher S ^a   Reitz, Allen B ^b   Rawls, Scott M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fox Chase Chemical Diversity Center   (United States)

Author keywords

Bath salt; Cathinone; Cocaine; Mephedrone; Methamphetamine; Rat; Sensitization

Indexed keywords

4' METHYLMETHCATHINONE; COCAINE; METHAMPHETAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS ALLERGY; DRUG EFFICACY; DRUG SENSITIZATION; LOCOMOTION; MALE; NONHUMAN; RAT; TREATMENT DURATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DRUG SYNERGISM; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; RATS;

EID: 84888205348     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000006     Document Type: Article

References (28)

1. Aarde SM, Angrish D, Barlow DJ, Wright MJ Jr, Vandewater SA, Creehan KM, et al. (2013). Mephedrone (4-methylmethcathinone) supports intravenous selfadministration in Sprague-Dawley and Wistar rats. Addict Biol 18:786-799.
2. Achat-Mendes C, Anderson KL, Itzhak Y (2003). Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 45:106-115. (Pubitemid 36695015)
3. Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF, et al. (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192-1203.
4. Baumann MH, Partilla JS, Lehner KR (2013). Psychoactive "bath salts": not so soothing. Eur J Pharmacol 698:1-5.
5. Brandon CL, Marinelli M, Baker LK, White FJ (2001). Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25:651-661. (Pubitemid 32995947)
6. Callaway CW, Geyer MA (1992). Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist. J Pharmacol Exp Ther 263:318-326.
7. Cameron K, Kolanos R, Verkariya R, De Felice L, Glennon RA (2013). Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of 'bath salts," produce opposite effects at the human dopamine transporter. Psychopharmacology (Berl) 227:493-499.
8. Cole JC, Sumnall HR, O'Shea E, Marsden CA (2003). Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl) 166:383-390. (Pubitemid 36469940)
9. Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE, McGregor IS (2003). Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol 482: 339-341. (Pubitemid 37505963)
10. Fletcher PJ, Robinson SR, Slippoy DL (2001). Pre-exposure to (+/-)3,4- methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology 25:195-203. (Pubitemid 32566341)
11. Gatch MB, Taylor CM, Forster MJ (2013). Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones. Behav Pharmacol 24:437-447.
12. Gregg R, Tallarida CS, Reitz A, McCurdy C, Rawls SM (2013). Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug Alcohol Depend [in press].
13. Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, et al. (2011). 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530-536.
14. Huang PK, Aarde SM, Angrish D, Houseknecht KL, Dickerson TJ, Taffe MA (2012). Contrasting effects of D-methamphetamine, 3,4- methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. Drug Alcohol Depend 126:168-175.
15. Itzhak Y, Ali SF, Achat CN, Anderson KL (2003). Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacology (Berl) 166:241-248. (Pubitemid 36384770)
16. Kalivas PW, Duffy P, White SR (1998). MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18:469-479. (Pubitemid 28202354)
17. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011). Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164:1949-1958.
18. Kovalevich J, Corley G, Yen W, Rawls SM, Langford D (2012). Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal. Am J Pathol 181:1921-1927.
19. Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, Rawls SM (2012). Mephedrone ('bath salt') elicits conditioned place preference and dopaminesensitive motor activation. Drug Alcohol Depend 126:257-262.
20. Modi GM, Yang PB, Swann AC, Dafny N (2006). Chronic exposure to MDMA (ecstasy) elicits behavioral sensitization in rats but fails to induce crosssensitization to other psychostimulants. Behav Brain Funct 2:1.
21. Morgan AE, Horan B, Dewey SL, Ashby CR (1997). Repeated administration of 3,4- methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study. Eur J Pharmacol 331:R1-R3. (Pubitemid 27312418)
22. Pierce RC, Bell K, Duffy P, Kalivas PW (1996). Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1560. (Pubitemid 26145933)
23. Prosser JM, Nelson LS (2012). The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8:33-42.
24. Robinson JE, Agoglia AE, Fish EW, Krouse MC, Malanga CJ (2012). Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine. Behav Brain Res 234:76-81.
25. Steketee JD, Kalivas PW (2011). Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 63:348-365.
26. Tallarida RJ (2011). Quantitative methods for assessing drug synergism. Genes Cancer 2:1003-1008.
27. Varner KJ, Daigle K, Weed PF, Lewis PB, Mahne SE, Sankaranarayanan A, Winsauer PJ (2013). Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats. Psychopharmacology (Berl) 225:675-685.
28. Winstock A, Mitcheson L, Ramsey J, Davies S, Puchnarewicz M, Marsden J (2011). Mephedrone: use, subjective effects and health risks. Addiction 106: 1991-1996.